By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
Wealth Beat NewsWealth Beat News
  • Home
  • News
  • Finance
  • Investing
  • Banks
  • Mortgage
  • Loans
  • Credit Cards
  • Small Business
  • Dept Management
Notification Show More
Aa
Wealth Beat NewsWealth Beat News
Aa
  • News
  • Finance
  • Investing
  • Banks
  • Mortgage
  • Loans
  • Credit Cards
  • Small Business
  • Dept Management
Follow US
Wealth Beat News > Banks > XRP Sales In Secondary Markets May Still Be The Sale Of Securities
Banks

XRP Sales In Secondary Markets May Still Be The Sale Of Securities

News
Last updated: 2023/07/13 at 7:58 PM
By News
Share
2 Min Read
SHARE

US District Judge Analisa Torres in New York ruled on Thursday that Ripple Labs Inc. sales of the XRP
XRP
token to institutional investors is a securities offering, but such sales are not securities when sold to the general public. The court did not rule on whether secondary market sales of XRP are offers or sales of securities.

The court order was in response to motions for summary judgement from both the SEC, as plaintiff, and Ripple Labs, Inc., Bradley Garlinghouse, and Christian A. Larsen, as defendants. The judge granted partial motions for both sides.

The actual case is still to be heard, and the judge will be setting a trial date.

In the meantime, there is still no certainty whether a secondary market sales of XRP constitutes the sale of a security. What is decided is that when Ripple Labs sold XRP to the general public through a digital asset exchange that such sales were not the sales of securities. Questions are still open about transactions over-the-counter or when the buyer and seller identities were known to each other.

A good step forward, and more clarity is necessary so that all the questions are answered.

Read the full article here

News July 13, 2023 July 13, 2023
Share this Article
Facebook Twitter Copy Link Print
Leave a comment Leave a comment

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Fast Four Quiz: Precision Medicine in Cancer

How much do you know about precision medicine in cancer? Test your knowledge with this quick quiz.
Get Started
Excelerate Energy: Nearby Best Energy-Source Cap-Gain Prospect (NYSE:EE)

The primary focus of this article is Excelerate Energy, Inc. (NYSE:EE). Investment…

Penske Is Steady, But The Road Ahead May Be Bumpy (NYSE:PAG)

Investing Thesis On Wednesday, Penske Automotive Group (NYSE:PAG) released a superficially encouraging…

Top Financial – No, Stop It, This Is Silly (NASDAQ:TOP)

TOP Financial Moves, yes, but why? TOP Financial (NASDAQ:TOP) was quite the…

You Might Also Like

Banks

Swiss Banque Pictet Admits Conspiring With Americans To Hide Funds

By News
Banks

The Beginning Of The End Of Bank-Fintech ‘Partnerships’

By News
Banks

6 Resources Investors Can Be Thankful For This Holiday Season

By News
Banks

The Evolution Of Bank-Fintech Partnerships

By News
Facebook Twitter Pinterest Youtube Instagram
Company
  • Privacy Policy
  • Terms & Conditions
  • Contact US
More Info
  • Newsletter
  • Finance
  • Investing
  • Small Business
  • Dept Management

Sign Up For Free

Subscribe to our newsletter and don't miss out on our programs, webinars and trainings.

I have read and agree to the terms & conditions

Join Community

2025 © wealthbeatnews.com. All Rights Reserved.

Join Us!

Subscribe to our newsletter and never miss our latest news, podcasts etc.

I have read and agree to the terms & conditions
Zero spam, Unsubscribe at any time.
Welcome Back!

Sign in to your account

Lost your password?